World Courier forms ‘personalized’ supply chain teams, opens four new offices

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/peshkov)
(Image: Getty/peshkov)
World Courier has created personalized supply chain teams to support direct-to-patient, cell and gene therapy, and clinical trials execution as the company experiences double-digit growth.

The specialty logistics company, part of AmerisourceBergen, has opened new offices Chengdu, China; Manila, Philippines; Vilnius, Lithuania; Belgrade, Serbia. The company is also expanding its facilities in Feltham, UK, and Boston, US.

Additionally, World Courier has introduced personalized supply chain teams to support direct-to-patient, cell and gene therapy, and clinical trials execution. The teams will work directly with customers to offer project management and customer service support.

“These urgent and critical products require a hands-on approach and the highest level of coordination, as minor delays can have a detrimental impact for the patient, sponsor and study,” ​said World Courier’s President Sam Herbert.

“The specific teams, fully devoted to these specialist areas, enable us to garner a more granular understanding of our customers’ needs while building scalable solutions,”​ he told us.

The company has seen double-digit growth in the areas of direct-to-patient, cell and gene therapy and specialty commercial supply chain, Herbert explained.

Additionally, he said the company has experienced an increasing demand for its services in emerging markets, such as Chengdu, China, Manila, Philippines, Vilnius, Lithuania, and Belgrade, Serbia.

Related news

Show more

Related products

show more

Import Risks & Clinical Supply Depots

Import Risks & Clinical Supply Depots

Catalent Pharma Solutions | 07-Nov-2018 | Case Study

A sponsor running a clinical trial in Israel arranged to ship their clinical trial product from Europe to a depot in Israel. With the protocol based in...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Products

View more

Webinars